A Phase Ii Study Of Nilotinib, A Novel Inhibitor Of C-Kit, Pdgfr, And Bcr-Abl, Administered To Patients With Systemic Mastocytosis.Andreas Hochhaus,Oliver G. Ottmann, STephanie Lauber,Timothy Hughes,Gregor Verhoef,Anthony P. Schwarer,Alois Gratwohl,Teresa Rafferty, Debra Resta,Norbert GattermannBLOOD(2006)引用 11|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要